Adamis Pharma files U.S. marketing application for fast-dissolving sublingual tadalafil tablet for ED - Seeking Alpha

Adamis Pharma files U.S. marketing application for fast-dissolving sublingual tadalafil tablet for ED  Seeking Alpha

Adamis Pharmaceuticals (ADMP) has filed an NDA with the FDA seeking approval for its fast-dissolving sublingual tadalafil tablet for the treatment of erect.